141 related articles for article (PubMed ID: 29802567)
1. TNF-R2 in tumor microenvironment as prognostic factor in epithelial ovarian cancer.
Nomelini RS; Borges Júnior LE; de Lima CA; Chiovato AFC; Micheli DC; Tavares-Murta BM; Murta EFC
Clin Exp Med; 2018 Nov; 18(4):547-554. PubMed ID: 29802567
[TBL] [Abstract][Full Text] [Related]
2. Chronological changes in circulating levels of soluble tumor necrosis factor receptors 1 and 2 in rats with carbon tetrachloride-induced liver injury.
Ijiri Y; Kato R; Sadamatsu M; Takano M; Okada Y; Tanaka K; Hayashi T
Toxicology; 2014 Feb; 316():55-60. PubMed ID: 24389507
[TBL] [Abstract][Full Text] [Related]
3. Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma.
Goto N; Tsurumi H; Takemura M; Hara T; Sawada M; Kasahara S; Kanemura N; Yamada T; Shimizu M; Takahashi T; Tomita E; Seishima M; Takami T; Moriwaki H
Eur J Haematol; 2006 Sep; 77(3):217-25. PubMed ID: 16856931
[TBL] [Abstract][Full Text] [Related]
4. Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study.
Marti CN; Khan H; Mann DL; Georgiopoulou VV; Bibbins-Domingo K; Harris T; Koster A; Newman A; Kritchevsky SB; Kalogeropoulos AP; Butler J;
Circ Heart Fail; 2014 Jan; 7(1):5-11. PubMed ID: 24323631
[TBL] [Abstract][Full Text] [Related]
5. [Changes in concentrations of tumor necrosis factor TNF and its soluble receptors type 1 (sTNF-r1) and type 2 (sTNF-R2) in serum of patients with ST-segment elevation myocardial infarction].
Mielczarek-Palacz A; Sikora J; Kondera-Anasz Z; Smycz M
Wiad Lek; 2011; 64(2):71-4. PubMed ID: 22026268
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of TNF-alpha and its soluble receptors in the plasma of patients with epithelial ovarian cancer.
Dobrzycka B; Terlikowski SJ; Kowalczuk O; Kinalski M
Eur Cytokine Netw; 2009 Sep; 20(3):131-4. PubMed ID: 19825522
[TBL] [Abstract][Full Text] [Related]
7. [Role of the TNF system in the pathomechanism of bronchial asthma].
Halász A; Cserháti E; Cseh K
Orv Hetil; 2002 Mar; 143(11):553-7. PubMed ID: 12583324
[TBL] [Abstract][Full Text] [Related]
8. Soluble fractions of tumor necrosis factor-alpha, interleukin-6 and of their receptors in toxic epidermal necrolysis: a comparison with second-degree burns.
Paquet P; Piérard GE
Int J Mol Med; 1998 Feb; 1(2):459-62. PubMed ID: 9852250
[TBL] [Abstract][Full Text] [Related]
9. Distinct expression and localization of TNF system in ovarian carcinoma tissues: possible involvement of TNF-α in morphological changes of ovarian cancerous cells.
Piura B; Medina L; Rabinovich A; Dyomin V; Levy RS; Huleihel M
Anticancer Res; 2014 Feb; 34(2):745-52. PubMed ID: 24511008
[TBL] [Abstract][Full Text] [Related]
10. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients.
Ohya M; Taniguchi A; Fukushima M; Nakai Y; Kawasaki Y; Nagasaka S; Kuroe A; Taki Y; Yoshii S; Hosokawa M; Inagaki N; Seino Y
Metabolism; 2005 Oct; 54(10):1297-301. PubMed ID: 16154427
[TBL] [Abstract][Full Text] [Related]
11. Early detection of increased tumour necrosis factor alpha (TNFalpha) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course.
Spielmann S; Kerner T; Ahlers O; Keh D; Gerlach M; Gerlach H
Acta Anaesthesiol Scand; 2001 Mar; 45(3):364-70. PubMed ID: 11207475
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha and its receptors in epithelial ovarian cancer.
Dobrzycka B; Terlikowski SJ; Garbowicz M; Niklińska W; Bernaczyk PS; Nikliński J; Kinalski M; Chyczewski L
Folia Histochem Cytobiol; 2009; 47(4):609-13. PubMed ID: 20430728
[TBL] [Abstract][Full Text] [Related]
13. Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents.
Moon YS; Kim DH; Song DK
Metabolism; 2004 Jul; 53(7):863-7. PubMed ID: 15254878
[TBL] [Abstract][Full Text] [Related]
14. The enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed in patients treated with beta-adrenoceptor antagonist.
Loppnow H; Werdan K; Werner C
Auton Autacoid Pharmacol; 2002 Apr; 22(2):83-92. PubMed ID: 12568125
[TBL] [Abstract][Full Text] [Related]
15. Resistance training enhances insulin-mediated glucose disposal with minimal effect on the tumor necrosis factor-alpha system in older hypertensives.
Reynolds TH; Supiano MA; Dengel DR
Metabolism; 2004 Mar; 53(3):397-402. PubMed ID: 15015154
[TBL] [Abstract][Full Text] [Related]
16. Plasma cytokine parameters and mortality in patients with chronic heart failure.
Rauchhaus M; Doehner W; Francis DP; Davos C; Kemp M; Liebenthal C; Niebauer J; Hooper J; Volk HD; Coats AJ; Anker SD
Circulation; 2000 Dec; 102(25):3060-7. PubMed ID: 11120695
[TBL] [Abstract][Full Text] [Related]
17. Lack of soluble TNF-receptors in women with recurrent spontaneous abortion and possibility for its correction.
Chernyshov VP; Vodyanik MA; Pisareva SP
Am J Reprod Immunol; 2005 Nov; 54(5):284-91. PubMed ID: 16212650
[TBL] [Abstract][Full Text] [Related]
18. Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumours.
Mielczarek-Palacz A; Kondera-Anasz Z; Sikora J
Arch Med Sci; 2012 Nov; 8(5):848-53. PubMed ID: 23185194
[TBL] [Abstract][Full Text] [Related]
19. The role of soluble TNF receptors for TNF-alpha in uveitis.
Sugita S; Takase H; Taguchi C; Mochizuki M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3246-52. PubMed ID: 17591895
[TBL] [Abstract][Full Text] [Related]
20. Proinflammatory cytokine activation is linked to apoptotic mediator, soluble Fas level in patients with chronic heart failure.
Kinugawa T; Kato M; Yamamoto K; Hisatome I; Nohara R
Int Heart J; 2012; 53(3):182-6. PubMed ID: 22790687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
